Dianthus Therapeutics, Inc. (DNTH)
41.43
+0.03
(+0.07%)
USD |
NASDAQ |
Dec 17, 16:00
41.42
-0.01
(-0.02%)
After-Hours: 20:00
Dianthus Therapeutics Total Liabilities (Quarterly): 30.99M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.958B |
| Lexicon Pharmaceuticals, Inc. | 85.77M |
| Day One Biopharmaceuticals, Inc. | 62.91M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 577.44M |
| Shareholders Equity (Quarterly) | 546.45M |
| Debt to Equity Ratio | 0.0024 |
| Current Ratio | 17.35 |
| Net Debt Paydown Yield | -0.01% |